Postoperative complications of vitrectomy alone versus vitrectomy with intravitreal bevacizumab pretreatment in the meta-analysis
| Complications | No of studies | Crude rate, n/N (%) | Percentage rate difference (95% CI) | p Value for overall effect | |
| Pars plana vitrectomy group | Intravitreal bevacizumab+pars plana vitrectomy group | ||||
| Early elevation of intraocular pressure (≥25 mm Hg) (≤1 week) | 31 3 5 | 13/66 | 12/67 | 1.08 (0.36 to 3.27) | 0.89 |
| Late elevation of intraocular pressure (≥25 mm Hg) (>1 week) | 31 3 6 | 8/57 | 0/48 | 17.00 (0.91 to 319.22) | 0.06 |
| Final retinal detachment | 31 3 4 | 5/51 | 2/54 | 2.44 (0.52 to 11.46) | 0.26 |
| Repeat vitrectomy | 24 9 | 3/42 | 1/46 | 2.69 (0.37 to 19.33) | 0.32 |